Edition:
United States

Insider Trading: INSYS Therapeutics Inc (INSY.OQ)

INSY.OQ on NASDAQ Stock Exchange Global Market

12.65USD
21 Feb 2017
Change (% chg)

$1.55 (+13.96%)
Prev Close
$11.10
Open
$11.26
Day's High
$12.66
Day's Low
$10.98
Volume
568,565
Avg. Vol
236,125
52-wk High
$21.21
52-wk Low
$8.70

BABICH MICHAEL L
Trading Date Type Shares Traded Price Shares Held
21 Sep 2015 Buy 16,068 $1.62 421,572
19 Mar 2015 Buy 5,000 $3.25 207,752
16 Mar 2015 Sell 13,300 $58.12 202,752
16 Mar 2015 Sell 12,500 $57.21 202,752
16 Mar 2015 Buy 27,400 $7.26 202,752
16 Mar 2015 Sell 1,600 $58.95 202,752
15 Mar 2015 Buy 30,000 $3.25 202,752
15 Mar 2015 Sell 2,330 $60.62 202,752
15 Mar 2015 Buy 1,845 $7.26 202,752
15 Mar 2015 Sell 8,224 $57.91 202,752
15 Mar 2015 Buy 45,755 $2.36 202,752
15 Mar 2015 Sell 23,500 $59.07 202,752
15 Mar 2015 Sell 13,546 $59.71 202,752

Institutional Holders

% Shares Owned: 37.33%
# of Holders: 193
Total Shares Held: 26,794,856
3 Mo. Net Change: -5,253,226
# New Positions: 22
# Closed Positions: 26
# Increased Positions: 74
# Reduced Positions: 81
# Net Buyers: -7

Officers & Directors

Name Age Since Current Position

Steven Meyer

59 2017 Chairman of the Board

Santosh Vetticaden

56 2017 Interim Chief Executive Officer

Darryl Baker

46 2012 Chief Financial Officer

Franc Fosse

43 2014 General Counsel, Corporate Secretary

Michael Babich

38 2015 Director

John Kapoor

72 2017 Director

Patrick Fourteau

68 2011 Independent Director

Pierre Lapalme

74 2011 Independent Director

Theodore Stanley

74 2013 Independent Director

Brian Tambi

72 2010 Independent Director